The Establishment of Dendritic Cell-Tumor Fusion Vaccines for Hormone Refractory Prostate Cancer Cell

PURPOSE: Dendritic cell (DC)-based tumor vaccine is an attractive modality for the treatment of hormone-refractory prostate cancer (HRPC) because it has some efficacy and few side effects in patients with poor general conditions. The aim of this study was to establish which is the most effective DC...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Kim, Tae-Beom, Park, Ho Ki, Chang, Joo Hyun, Choi, In Ho, Kim, Khae Hawn, Yoon, Sang Jin, Lee, Min Sung, Jung, Han, Kim, Choung-Soo
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: The Korean Urological Association 2010
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2855480/
https://ncbi.nlm.nih.gov/pubmed/20414428
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4111/kju.2010.51.2.139
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller